Adore Beauty’s COVID-19 boom shows no signs of a triumphant return
Nick Sundich, May 1, 2023
You have to feel sorry for Adore Beauty (ASX:ABY) and its shareholders (at least some of them). Its 3Q23 was more of the same in the post-COVID era for the online beauty retailer, except it had the additional news that the company’s founders were stepping down from the business.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
A good business, but a bad listing
Adore Beauty was founded back in 1999 and listed in the ASX in October 2020.
The company had recorded substantial growth during its existence, but it particularly grew during the pandemic when people were locked down and shopping online.
The bankers who priced the float, the company and investors who backed the company overestimated the loyalty of those COVID customers.
They also priced the float at a ridiculously high price – at 96x of its FY21 EV/EBITDA. In fairness, all but $40m of the $269.5m in proceeds raised went to cash out existing shareholders so
After listing at $6.75, shares are barely over $1 – a decline of nearly 85%.
3Q23 results more of the same?
Almost all companies will spin their results as better than they are and that’s what Adore Beauty did.
Revenue was $41.3m, down 3.3% in 12 months and up 4.9% in two years. Active customers were 793,000 – down 3% in 2 years and down 10% on the prior corresponding period.
The company also announced that co-founders Kate Morris and James Height would be stepping down as part-time executives.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial expires automatically.
Blog Categories
Recent Posts
What are nominee shareholders? Have they got anything secret to hide from the rest of the market?
Let’s take a look at who nominee shareholders are. Have you ever seen a substantial shareholder notice lodged with your…
Cochlear (ASX:COH) is a long term growth story you should listen too
Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of…